Literature DB >> 28412471

Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.

Jong-Suep Baek1, Cheong-Weon Cho2.   

Abstract

Curcumin has been reported to exhibit potent anticancer effects. However, poor solubility, bioavailability and stability of curcumin limit its in vivo efficacy for the cancer treatment. Solid lipid nanoparticles (SLN) are a promising delivery system for the enhancement of bioavailability of hydrophobic drugs. However, burst release of drug from SLN in acidic environment limits its usage as oral delivery system. Hence, we prepared N-carboxymethyl chitosan (NCC) coated curcumin-loaded SLN (NCC-SLN) to inhibit the rapid release of curcumin in acidic environment and enhance the bioavailability. The NCC-SLN exhibited suppressed burst release in simulated gastric fluid while sustained release was observed in simulated intestinal fluid. Furthermore, NCC-SLN exhibited increased cytotoxicity and cellular uptake on MCF-7 cells. The lymphatic uptake and oral bioavailability of NCC-SLN were found to be 6.3-fold and 9.5-fold higher than that of curcumin solution, respectively. These results suggest that NCC-SLN could be an efficient oral delivery system for curcumin.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioavailability; Curcumin; N-carboxymethyl chitosan; Oral drug delivery; Solid lipid nanoparticle

Mesh:

Substances:

Year:  2017        PMID: 28412471     DOI: 10.1016/j.ejpb.2017.04.013

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  26 in total

1.  Oral Drug Delivery Technologies-A Decade of Developments.

Authors:  G Kaur; M Arora; M N V Ravi Kumar
Journal:  J Pharmacol Exp Ther       Date:  2019-04-22       Impact factor: 4.030

Review 2.  Innovations in lymph node targeting nanocarriers.

Authors:  Jihoon Kim; Paul A Archer; Susan N Thomas
Journal:  Semin Immunol       Date:  2021-11-24       Impact factor: 11.130

3.  PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer.

Authors:  Abdelrahman Y Sherif; Gamaleldin I Harisa; Fars K Alanazi; Fahd A Nasr; Ali S Alqahtani
Journal:  Int J Nanomedicine       Date:  2022-07-28

4.  Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line.

Authors:  Abdelrahman Y Sherif; Gamaleldin I Harisa; Fars K Alanazi; Fahd A Nasr; Ali S Alqahtani
Journal:  AAPS PharmSciTech       Date:  2022-07-01       Impact factor: 4.026

Review 5.  Targeting Lymphatics for Nanoparticle Drug Delivery.

Authors:  Jacob McCright; Ritika Naiknavare; Jenny Yarmovsky; Katharina Maisel
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

6.  Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride.

Authors:  Marianne Joseph Naguib; Ibrahim Elsayed; Mahmoud Hassan Teaima
Journal:  Int J Nanomedicine       Date:  2021-04-21

7.  Sustained Cytotoxicity of Wogonin on Breast Cancer Cells by Encapsulation in Solid Lipid Nanoparticles.

Authors:  Jong-Suep Baek; Young-Guk Na; Cheong-Weon Cho
Journal:  Nanomaterials (Basel)       Date:  2018-03-13       Impact factor: 5.076

8.  Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.

Authors:  Alaa Mohamed Nazief; Passainte Saber Hassaan; Hoda Mahmoud Khalifa; Magda Samir Sokar; Amal Hassan El-Kamel
Journal:  Int J Nanomedicine       Date:  2020-02-18

9.  Development of tamoxifen-loaded surface-modified nanostructured lipid carrier using experimental design: in vitro and ex vivo characterisation.

Authors:  Ganesan Poovi; Narayanasamy Damodharan
Journal:  IET Nanobiotechnol       Date:  2020-06       Impact factor: 1.847

Review 10.  Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases.

Authors:  Palanivel Ganesan; Prakash Ramalingam; Govindarajan Karthivashan; Young Tag Ko; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.